Education
About Us
Working with TipRanks
Follow Us
Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN
TVGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.26 - $3.09
Previous CloseN/A
Volume2.03M
Average Volume (3M)590.77K
Market Cap
$222.83M
Enterprise Value$221.18M
Total Cash (Recent Filing)$1.97M
Total Debt (Recent Filing)$1.82M
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Aug 14, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding185,693,440
10 Day Avg. Volume282,214
30 Day Avg. Volume590,770
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)-25.50
Price to Sales (P/S)0.00
P/FCF Ratio-17.12
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue278.85
Enterprise Value/Gross Profit2.25K
Enterprise Value/Ebitda-4.68
Forecast
1Y Price Target
$10.00Price Target Upside733.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Tevogen Bio Holdings News
PremiumCompany Announcements
Tevogen Bio Grants Restricted Stock to CEO
PremiumCompany Announcements
Tevogen Bio Holdings Enters $50M Sales AgreementOptions Prices
Currently, No data available
---
Ownership Overview
77.55% Insiders
0.84% Mutual Funds
0.04% Other Institutional Investors
20.32% Public Companies and Individual Investors
TVGN FAQ
What was Tevogen Bio Holdings’s price range in the past 12 months?
Tevogen Bio Holdings lowest stock price was $0.26 and its highest was $3.09 in the past 12 months.
What is Tevogen Bio Holdings’s market cap?
Tevogen Bio Holdings’s market cap is $222.83M.
When is Tevogen Bio Holdings’s upcoming earnings report date?
Tevogen Bio Holdings’s upcoming earnings report date is Aug 14, 2025 which is in 28 days.
How were Tevogen Bio Holdings’s earnings last quarter?
Currently, no data Available
Is Tevogen Bio Holdings overvalued?
According to Wall Street analysts Tevogen Bio Holdings’s price is currently Undervalued.
Does Tevogen Bio Holdings pay dividends?
Tevogen Bio Holdings does not currently pay dividends.
What is Tevogen Bio Holdings’s EPS estimate?
Tevogen Bio Holdings’s EPS estimate is -0.05.
How many shares outstanding does Tevogen Bio Holdings have?
Tevogen Bio Holdings has 185,693,440 shares outstanding.
What happened to Tevogen Bio Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tevogen Bio Holdings?
Among the largest hedge funds holding Tevogen Bio Holdings’s share is Saba Capital Management. It holds Tevogen Bio Holdings’s shares valued at 0.
Tevogen Bio Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (733.33% Upside)
$10.00 (733.33% Upside)
Hedge Fund Trend
Decreased
By 5.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
68.49%
12-Months-Change
Fundamentals
Return on Equity
-124.74%
Trailing 12-Months
Asset Growth
21.10%
Trailing 12-Months
Company Description
Tevogen Bio Holdings
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Technical Analysis
Codexis
―
Cidara Therapeutics
―
Corvus Pharmaceuticals
―
Nuvectis Pharma
―
CARGO Therapeutics, Inc.
―